|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-OtherNew Chemistry-Other Posters |
1 Molecular Medicine and Nuclear Medicine; 2 Nuclear Medicine, Kyungpook National University, Dae-gu, South Korea
1279
Objectives: Labeling with F-18 (t1/2=110min) and Cu-64 (t1/2=12.7h) has been most devoted for monitoring movement of cells over a time course. However, these radionuclides do not have sufficiently long half-life for long-term cell trafficking study. Here we report a preparation of long term cell trafficking agent with I-131 (t1/2)=8d. This agent was used to radiolabel different cells by absorption into cell membranes.
Methods: Treatment of 4-iodobenzoyl chloride with oleyl alcohol was yielded oleyl-4-iodobenzoate, followed by nucleophilic aromatic substitution with hexabutyl tin. Oleyl-4-(tributylstannyl) benzoate was treated with 3% H2O2, 1M HCl, and [131I]NaI to give oleyl-4-[131I]-iodobenzoate ([131I]OIB). Cell labeling was accomplished by simply incubation of [131I]OIB and cells in PBS, followed by successive washing and isolation of the cells by centrifugation. Over 2 weeks, gamma camera images were measured after myocardium injection of the [131I]OIB-labeled cells.
Results: ([131I]OIB)was prepared in three steps efficiently. The radiochemical yield of [131I]OIB was higher than 50%. The radiolabeled [131I]OIB was obtained in high radiochemical purity (> 93%) after HPLC purification. The yield of cell labeling of [131I]OIB with L6, H9C2, and Hela cells was 32±6.9%,27±5.2%, and 22±6.7%, respectively. Gamma camera imaging of implanted [131I]OIB-labeled L6 cells showed high retention in rat heart up to 2 weeks.
Conclusions: [131I]OIB was simple to prepare and cells were labeled effectively. [131I]OIB and its other radioiodine analogs, [124/125I]OIB are expected to play a role as a long term cell trafficking agent.
Research Support: This work was supported by the Brain Korea 21 Project in 2008.
| ||||||||||||||||||||||||||||||||||||||